0000805928-22-000062.txt : 20220603
0000805928-22-000062.hdr.sgml : 20220603
20220603160633
ACCESSION NUMBER: 0000805928-22-000062
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220601
FILED AS OF DATE: 20220603
DATE AS OF CHANGE: 20220603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Freitag Gregory Gene
CENTRAL INDEX KEY: 0001492710
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36046
FILM NUMBER: 22994373
MAIL ADDRESS:
STREET 1: 13631 PROGRESS BLVD.
CITY: ALACHUA
STATE: FL
ZIP: 32615
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axogen, Inc.
CENTRAL INDEX KEY: 0000805928
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 411301878
STATE OF INCORPORATION: MN
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13631 PROGRESS BLVD.
STREET 2: SUITE 400
CITY: ALACHUA
STATE: FL
ZIP: 32615
BUSINESS PHONE: (386) 462-6817
MAIL ADDRESS:
STREET 1: 13631 PROGRESS BLVD.
STREET 2: SUITE 400
CITY: ALACHUA
STATE: FL
ZIP: 32615
FORMER COMPANY:
FORMER CONFORMED NAME: AxoGen, Inc.
DATE OF NAME CHANGE: 20111004
FORMER COMPANY:
FORMER CONFORMED NAME: LECTEC CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
wf-form4_165428677346545.xml
FORM 4
X0306
4
2022-06-01
0
0000805928
Axogen, Inc.
AXGN
0001492710
Freitag Gregory Gene
13631 PROGRESS BLVD.
SUITE 400
ALACHUA
FL
32615
1
0
0
0
Common Stock
2022-06-01
4
M
0
3036
0
A
358811
D
Restricted Stock Units
2022-06-01
4
M
0
3036
0
D
Common Stock
3036.0
0
D
Employee Stock Option (right to purchase)
9.29
2022-06-01
4
A
0
11811
0
A
2032-06-01
Common Stock
11811.0
11811
D
Restricted Stock Units
2022-06-01
4
A
0
6459
0
A
Common Stock
6459.0
6459
D
This reflects the number of restricted stock units that vested on June 1, 2022.
Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date.
Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.
/s/Gregory Freitag
2022-06-03